137 related articles for article (PubMed ID: 9934769)
1. Simultaneous pancreatitis and hepatitis associated with trimethoprim-sulfamethoxazole.
Brett AS; Shaw SV
Am J Gastroenterol; 1999 Jan; 94(1):267-8. PubMed ID: 9934769
[TBL] [Abstract][Full Text] [Related]
2. Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim.
Alberti-Flor JJ; Hernandez ME; Ferrer JP; Howell S; Jeffers L
Am J Gastroenterol; 1989 Dec; 84(12):1577-9. PubMed ID: 2596461
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
5. Possible Sulfamethoxazole/Trimethoprim-Induced Pancreatitis in a Complicated Adolescent Patient Posttraumatic Injury.
Dickey SE; Mabry WA; Hamilton LA
J Pharm Pract; 2015 Aug; 28(4):419-24. PubMed ID: 26040998
[TBL] [Abstract][Full Text] [Related]
6. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis. Inadvertent rechallenge.
Thies PW; Dull WL
Arch Intern Med; 1984 Aug; 144(8):1691-2. PubMed ID: 6331808
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-Sulfamethoxazole Associated Drug-Induced Liver Injury in Pediatrics: A Systematic Review.
Burgos RM; Reynolds KM; Williams J; Li W; Yan CH
Pediatr Infect Dis J; 2020 Sep; 39(9):824-829. PubMed ID: 32282528
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia secondary to trimethoprim/sulfamethoxazole administration in a renal transplant patient.
Johnson JA; Kappel JE; Sharif MN
Ann Pharmacother; 1993 Mar; 27(3):304-6. PubMed ID: 8453166
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole-induced aseptic meningitis.
Wambulwa C; Bwayo S; Laiyemo AO; Lombardo F
J Natl Med Assoc; 2005 Dec; 97(12):1725-8. PubMed ID: 16396068
[TBL] [Abstract][Full Text] [Related]
11. Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report.
van Asperdt JAA; De Moor RA
BMC Pediatr; 2021 Aug; 21(1):345. PubMed ID: 34399711
[TBL] [Abstract][Full Text] [Related]
12. Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.
Li YJ; Phillips EJ; Dellinger A; Nicoletti P; Schutte R; Li D; Ostrov DA; Fontana RJ; Watkins PB; Stolz A; Daly AK; Aithal GP; Barnhart H; Chalasani N;
Hepatology; 2021 Jan; 73(1):268-281. PubMed ID: 32270503
[TBL] [Abstract][Full Text] [Related]
13. Possible Trimethoprim-Sulfamethoxazole-Induced Hemolytic Anemia: A Case Report.
Williams MF; Doss EP; Montgomery M
J Pharm Pract; 2017 Dec; 30(6):653-657. PubMed ID: 29121838
[TBL] [Abstract][Full Text] [Related]
14. Virgin coconut oil protects against liver damage in albino rats challenged with the anti-folate combination, trimethoprim-sulfamethoxazole.
Otuechere CA; Madarikan G; Simisola T; Bankole O; Osho A
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):249-53. PubMed ID: 24285126
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group.
Bonfanti P; Pusterla L; Parazzini F; Libanore M; Cagni AE; Franzetti M; Faggion I; Landonio S; Quirino T
Biomed Pharmacother; 2000 Feb; 54(1):45-9. PubMed ID: 10721462
[TBL] [Abstract][Full Text] [Related]
16. Interstitial lung disease during trimethoprim/sulfamethoxazole administration.
Yuzurio S; Horita N; Shiota Y; Kanehiro A; Tanimoto M
Acta Med Okayama; 2010 Jun; 64(3):181-7. PubMed ID: 20596129
[TBL] [Abstract][Full Text] [Related]
17. Recurrent pancreatitis after trimethoprim-sulfamethoxazole rechallenge.
Versleijen MW; Naber AH; Riksen NP; Wanten GJ; Debruyne FM
Neth J Med; 2005; 63(7):275-7. PubMed ID: 16093580
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review.
Liu P; Ranches GP; Gold JA
BMC Pharmacol Toxicol; 2018 Nov; 19(1):76. PubMed ID: 30458864
[TBL] [Abstract][Full Text] [Related]
19. Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Chisholm-Burns MA; Patanwala AE; Spivey CA
Am J Health Syst Pharm; 2010 Jan; 67(2):123-7. PubMed ID: 20065266
[TBL] [Abstract][Full Text] [Related]
20. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
